INRAYUS Trademark

Trademark Overview


On Tuesday, July 30, 2024, a trademark application was filed for INRAYUS with the United States Patent and Trademark Office. The USPTO has given the INRAYUS trademark a serial number of 98673823. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, September 2, 2025. This trademark is owned by Sumitomo Pharma America, Inc.. The INRAYUS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating central nervous system diseases or disorders; pharmaceutical preparations for treating schizophrenia; pharmaceutical preparations for treating cognitive disorders; pharmaceutical preparations for treating major depressive disorder; pharmaceutical preparations for treating generalized anxiety disorder
inrayus

General Information


Serial Number98673823
Word MarkINRAYUS
Filing DateTuesday, July 30, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, September 2, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 2, 2025

Trademark Statements


Goods and ServicesPharmaceutical preparations for treating central nervous system diseases or disorders; pharmaceutical preparations for treating schizophrenia; pharmaceutical preparations for treating cognitive disorders; pharmaceutical preparations for treating major depressive disorder; pharmaceutical preparations for treating generalized anxiety disorder

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 30, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSumitomo Pharma America, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMarlborough, MA 01752

Party NameSumitomo Pharma America, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMarlborough, MA 01752

Trademark Events


Event DateEvent Description
Tuesday, July 30, 2024NEW APPLICATION ENTERED
Tuesday, July 30, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 6, 2025ASSIGNED TO EXAMINER
Monday, February 10, 2025NON-FINAL ACTION WRITTEN
Monday, February 10, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 10, 2025NON-FINAL ACTION E-MAILED
Wednesday, March 26, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, July 31, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 31, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 31, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 1, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 27, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 2, 2025PUBLISHED FOR OPPOSITION
Tuesday, September 2, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, March 26, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED